Paula Allen Greene
Examiner (ID: 10893, Phone: (571)272-2623 , Office: P/2912 )
Most Active Art Unit | 2912 |
Art Unit(s) | 2900, 0, 2912, 2904, 2902 |
Total Applications | 9387 |
Issued Applications | 9275 |
Pending Applications | 13 |
Abandoned Applications | 98 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18895503
[patent_doc_number] => 20240010988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/449625
[patent_app_country] => US
[patent_app_date] => 2023-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18449625
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/449625 | GENETICALLY MODIFIED PRIMARY CELLS FOR ALLOGENEIC CELL THERAPY | Aug 13, 2023 | Pending |
Array
(
[id] => 18879517
[patent_doc_number] => 20240002886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 18/447536
[patent_app_country] => US
[patent_app_date] => 2023-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/447536 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Aug 9, 2023 | Pending |
Array
(
[id] => 18923320
[patent_doc_number] => 20240026324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 18/447515
[patent_app_country] => US
[patent_app_date] => 2023-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18447515
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/447515 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Aug 9, 2023 | Pending |
Array
(
[id] => 18879453
[patent_doc_number] => 20240002822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 18/356013
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/356013 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Jul 19, 2023 | Pending |
Array
(
[id] => 18817780
[patent_doc_number] => 20230392120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => ENGINEERING CELL LINES CAPABLE OF PROLIFERATION IN GROWTH FACTOR FREE MEDIA FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/331092
[patent_app_country] => US
[patent_app_date] => 2023-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331092 | ENGINEERING CELL LINES CAPABLE OF PROLIFERATION IN GROWTH FACTOR FREE MEDIA FORMULATIONS | Jun 6, 2023 | Pending |
Array
(
[id] => 18844938
[patent_doc_number] => 20230407342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => CRISPR SYSTEMS WITH ENGINEERED DUAL GUIDE NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/190063
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18190063
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/190063 | CRISPR SYSTEMS WITH ENGINEERED DUAL GUIDE NUCLEIC ACIDS | Mar 23, 2023 | Pending |
Array
(
[id] => 18739594
[patent_doc_number] => 20230348552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => USE NOVEL LIGHT SENSITIVE CHANNEL PROTEIN VR 1.0 IN PREPARATION OF RETINAL PHOTORECEPTOR CELL DEGENERATIVE DISEASE DRUG
[patent_app_type] => utility
[patent_app_number] => 18/120007
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120007 | USE NOVEL LIGHT SENSITIVE CHANNEL PROTEIN VR 1.0 IN PREPARATION OF RETINAL PHOTORECEPTOR CELL DEGENERATIVE DISEASE DRUG | Mar 9, 2023 | Pending |
Array
(
[id] => 18530270
[patent_doc_number] => 20230235340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Process for extracellular secretion of Brazzein
[patent_app_type] => utility
[patent_app_number] => 18/109759
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109759 | Process for extracellular secretion of Brazzein | Feb 13, 2023 | Pending |
Array
(
[id] => 18649769
[patent_doc_number] => 20230295590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES
[patent_app_type] => utility
[patent_app_number] => 18/161560
[patent_app_country] => US
[patent_app_date] => 2023-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/161560 | Engineered meganucleases that target human mitochondrial genomes | Jan 29, 2023 | Issued |
Array
(
[id] => 18628508
[patent_doc_number] => 20230287373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS, ENZYMES AND GUIDE SCAFFOLDS OF CAS9 ORTHOLOGS AND VARIANTS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 18/101867
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101867 | ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS, ENZYMES AND GUIDE SCAFFOLDS OF CAS9 ORTHOLOGS AND VARIANTS FOR SEQUENCE MANIPULATION | Jan 25, 2023 | Pending |
Array
(
[id] => 18786433
[patent_doc_number] => 20230374545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => AAV CAPSID DESIGNS
[patent_app_type] => utility
[patent_app_number] => 18/150477
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150477 | AAV CAPSID DESIGNS | Jan 4, 2023 | Pending |
Array
(
[id] => 18887963
[patent_doc_number] => 11866728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Engineered retrons and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/087673
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 71
[patent_no_of_words] => 114942
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087673
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/087673 | Engineered retrons and methods of use | Dec 21, 2022 | Issued |
Array
(
[id] => 18861889
[patent_doc_number] => 20230416324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ALTERNATIVE NUCLEIC ACID MOLECULES CONTAINING REDUCED URACIL CONTENT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/049582
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049582
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049582 | ALTERNATIVE NUCLEIC ACID MOLECULES CONTAINING REDUCED URACIL CONTENT AND USES THEREOF | Oct 24, 2022 | Pending |
Array
(
[id] => 18932507
[patent_doc_number] => 11884915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Guide RNAs with chemical modification for prime editing
[patent_app_type] => utility
[patent_app_number] => 17/931535
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 22388
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931535 | Guide RNAs with chemical modification for prime editing | Sep 11, 2022 | Issued |
Array
(
[id] => 17867445
[patent_doc_number] => 20220290181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => CODON OPTIMIZED RPGRORF15 GENES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/825665
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/825665 | CODON OPTIMIZED RPGRORF15 GENES AND USES THEREOF | May 25, 2022 | Abandoned |
Array
(
[id] => 18195972
[patent_doc_number] => 20230049491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Adeno-Associated Virus Vector Delivery of a Fragment of Micro-Dystrophin to Treat Muscular Dystrophy
[patent_app_type] => utility
[patent_app_number] => 17/751195
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751195 | Adeno-Associated Virus Vector Delivery of a Fragment of Micro-Dystrophin to Treat Muscular Dystrophy | May 22, 2022 | Pending |
Array
(
[id] => 17836418
[patent_doc_number] => 20220273723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Immunocompetent Cell and Expression Vector Expressing Regulatory Factors of Immune Function
[patent_app_type] => utility
[patent_app_number] => 17/748889
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748889 | Immunocompetent cell and expression vector expressing regulatory factors of immune function | May 18, 2022 | Issued |
Array
(
[id] => 18169974
[patent_doc_number] => 20230036585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/738585
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738585 | NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS | May 5, 2022 | Pending |
Array
(
[id] => 17930130
[patent_doc_number] => 20220325255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS TARGETING TRIM7
[patent_app_type] => utility
[patent_app_number] => 17/710464
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710464 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS TARGETING TRIM7 | Mar 30, 2022 | Pending |
Array
(
[id] => 17946121
[patent_doc_number] => 20220333138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING F8 GENE FUNCTION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/654300
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654300 | Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof | Mar 9, 2022 | Issued |